Cargando…

The Roles of CD38 and CD157 in the Solid Tumor Microenvironment and Cancer Immunotherapy

The tumor microenvironment (TME) consists of extracellular matrix proteins, immune cells, vascular cells, lymphatics and fibroblasts. Under normal physiological conditions, tissue homeostasis protects against tumor development. However, under pathological conditions, interplay between the tumor and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wo, Yu Jun, Gan, Adelia Shin Ping, Lim, Xinru, Tay, Isabel Shu Ying, Lim, Sherlly, Lim, Jeffrey Chun Tatt, Yeong, Joe Poh Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017359/ https://www.ncbi.nlm.nih.gov/pubmed/31861847 http://dx.doi.org/10.3390/cells9010026

Ejemplares similares

Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma
por: Ng, Harry Ho Man, et al.
Publicado: (2020)

Immunohistochemical scoring of LAG-3 in conjunction with CD8 in the tumor microenvironment predicts response to immunotherapy in hepatocellular carcinoma
por: Cheung, Chun Chau Lawrence, et al.
Publicado: (2023)

CD38, CD157, and RAGE as Molecular Determinants for Social Behavior
por: Higashida, Haruhiro, et al.
Publicado: (2019)

CD38 marks the exhausted CD8(+) tissue-resident memory T cells in hepatocellular carcinoma
por: Reolo, Marie J. Y., et al.
Publicado: (2023)

The CD38/CD157 mammalian gene family: An evolutionary paradigm for other leukocyte surface enzymes
por: Deaglio, Silvia, et al.
Publicado: (2006)

Transcriptional Spatial Profiling of Cancer Tissues in the Era of Immunotherapy: The Potential and Promise
por: Nerurkar, Sanjna Nilesh, et al.
Publicado: (2020)

Distinct physical condition and social behavior phenotypes of CD157 and CD38 knockout mice during aging
por: Gerasimenko, Maria, et al.
Publicado: (2020)

The Good, the Bad and the Unknown of CD38 in the Metabolic Microenvironment and Immune Cell Functionality of Solid Tumors
por: Konen, Jessica M., et al.
Publicado: (2019)

Remission of social behavior impairment by oral administration of a precursor of NAD in CD157, but not in CD38, knockout mice
por: Gerasimenko, Maria, et al.
Publicado: (2023)

Expression of CD38 on Macrophages Predicts Improved Prognosis in Hepatocellular Carcinoma
por: Lam, Jian Hang, et al.
Publicado: (2019)

The Many Facets of CD38 in Lymphoma: From Tumor–Microenvironment Cell Interactions to Acquired Resistance to Immunotherapy
por: Calabretta, Eleonora, et al.
Publicado: (2020)

Oxytocin Dynamics in the Body and Brain Regulated by the Receptor for Advanced Glycation End-Products, CD38, CD157, and Nicotinamide Riboside
por: Higashida, Haruhiro, et al.
Publicado: (2022)

EZH2 targeting induces CD38 upregulation and response to anti-CD38 immunotherapies in multiple myeloma
por: Chemlal, Djamila, et al.
Publicado: (2023)

Expanding anti-CD38 immunotherapy for lymphoid malignancies
por: Wang, Xu, et al.
Publicado: (2022)

CD38-NAD(+)-Sirt1 axis in T cell immunotherapy
por: Chatterjee, Shilpak, et al.
Publicado: (2019)

Establishment and Characterization of Humanized Mouse NPC-PDX Model for Testing Immunotherapy
por: Liu, Wai Nam, et al.
Publicado: (2020)

Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation
por: Costa, Federica, et al.
Publicado: (2017)

Prognostic value of CD8 + PD-1+ immune infiltrates and PDCD1 gene expression in triple negative breast cancer
por: Yeong, Joe, et al.
Publicado: (2019)

Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy
por: Tan, Wei Chang Colin, et al.
Publicado: (2020)

Liver fibrosis and CD206(+) macrophage accumulation are suppressed by anti-GM-CSF therapy
por: Tan-Garcia, Alfonso, et al.
Publicado: (2019)

CD157 Confers Host Resistance to Mycobacterium tuberculosis via TLR2-CD157-PKCzeta-Induced Reactive Oxygen Species Production
por: Yang, Qianting, et al.
Publicado: (2019)

Targeting CD24 as a novel immunotherapy for solid cancers
por: Yang, Yan, et al.
Publicado: (2023)

Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapy
por: Kashyap, Abhishek S., et al.
Publicado: (2020)

Evaluation of CD47 in the Suppressive Tumor Microenvironment and Immunotherapy in Prostate Cancer
por: Wang, Qianqian, et al.
Publicado: (2023)

Functional Change of Effector Tumor-Infiltrating CCR5(+)CD38(+)HLA-DR(+)CD8(+) T Cells in Glioma Microenvironment
por: Chen, Pin-Yuan, et al.
Publicado: (2019)

Phenotyping and Target Expression Profiling of CD34(+)/CD38(−) and CD34(+)/CD38(+) Stem- and Progenitor cells in Acute Lymphoblastic Leukemia
por: Blatt, Katharina, et al.
Publicado: (2018)

CD38 in Neurodegeneration and Neuroinflammation
por: Guerreiro, Serge, et al.
Publicado: (2020)

Impaired learning and memory in CD38 null mutant mice
por: Kim, Somi, et al.
Publicado: (2016)

HLA Desensitization in Solid Organ Transplantation: Anti-CD38 to Across the Immunological Barriers
por: Joher, Nizar, et al.
Publicado: (2021)

Challenges in Immunotherapy Presented by the Glioblastoma Multiforme Microenvironment
por: Jackson, Christopher, et al.
Publicado: (2011)

Interferon gamma selectively inhibits very primitive CD342+CD38- and not more mature CD34+CD38+ human hematopoietic progenitor cells
Publicado: (1994)

CD38 and Anti-CD38 Monoclonal Antibodies in AL Amyloidosis: Targeting Plasma Cells and beyond
por: Roccatello, Dario, et al.
Publicado: (2020)

Controversy in the Use of CD38 Antibody for Treatment of Myeloma: Is High CD38 Expression Good or Bad?
por: Plesner, Torben, et al.
Publicado: (2020)

Heterogeneity of CD34 and CD38 expression in acute B lymphoblastic leukemia cells is reversible and not hierarchically organized
por: Jiang, Zhiwu, et al.
Publicado: (2016)

Responses of CD27(+)CD38(+) plasmablasts, and CD24(hi)CD27(hi) and CD24(hi)CD38(hi) regulatory B cells during primary dengue virus 2 infection
por: Lei, Chenshuang, et al.
Publicado: (2021)

The role of CD38 in HIV infection
por: Lu, Liqi, et al.
Publicado: (2021)

CD38 in Advanced Prostate Cancers
por: Guo, Christina, et al.
Publicado: (2021)

Targeting CD38 for acute leukemia
por: Zhong, Xushu, et al.
Publicado: (2022)

Decreased levels of T follicular helper (CD4+CXCR5+) cells and CD27+CD38+ and CD27+CD38− B cells in ankylosing spondylitis patients correlate with markers of inflammation
por: Lejon, Kristina, et al.
Publicado: (2022)

CD27(hi)CD38(hi) plasmablasts are activated B cells of mixed origin with distinct function
por: Rouers, Angeline, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_71r9sevthe233f6enuhaqpd0vc